ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRI-Guided radiation tailors treatment for anal cancer patients
Disease control Recruiting nowThis phase 2 trial tests a new way to deliver radiation therapy for anal cancer using MRI guidance to adjust doses based on each patient's risk level. About 80 adults with anal squamous cell carcinoma will receive different radiation schedules depending on their tumor risk group.…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New hope for tough cancers: EVOLVE104 trial begins
Disease control Recruiting nowThis early-stage trial tests a new drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell cancer (lung, esophagus, skin, and others). The main goals are to check the drug's safety and find the best dose. About 160 participants who have alre…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Daily custom radiation plans aim to spare healthy tissue in anal cancer
Symptom relief Recruiting nowThis study tests whether adjusting the radiation plan each day based on the patient's current anatomy can better target the tumor and reduce harm to nearby organs. It involves 20 adults with advanced anal cancer. The main goal is to see if this approach is practical and safe.
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 11, 2026 12:12 UTC